Atenolol rescues premature mortality in genetic mouse models of sudden unexpected death in epilepsy
Epilepsia · 2026-01 · 67 (1) · 448-462
DOI: 10.1111/epi.18642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 24.09.2025. Verfasst von Ming S Soh und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Sudden Unexpected Death in Epilepsy, ERG1 Potassium Channel, Atenolol, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Anonymous Philanthropic Gift, Australia's Medical Research Future Fund, CURE Epilepsy.
Abstract (Originalsprache)
Objective
Sudden unexpected death in epilepsy (SUDEP) is the leading cause of premature mortality in epilepsy. Genetic studies have identified that loss‐of‐function (LOF) KCNH2 variants are enriched in SUDEP patients, suggesting that they may act as a risk factor. KCNH2 encodes the K V 11.1 channel, with LOF pathogenic variants a cause of long‐QT syndrome (LQTS), increasing the risk of arrhythmia and sudden cardiac death. Here, we engineered preclinical rodent models that combine epilepsy‐causing pathogenic variants with heterozygous Kcnh2 knockout mice to explore the impact of reduced K V 11.1 channel function on mortality.
Methods
Both the Gabrg2 R43Q/+ and Hcn1 M294L/+ genetic mouse models of monogenic epilepsy were crossed with Kcnh2 +/− mice. All genotypes were video‐recorded post‐weaning and time to death was measured. Additional mice underwent surgery to enable simultaneous electrocorticography and electrocardiography recordings. Atenolol was delivered in drinking water to a subset of mice.
Results
Both single mutant Gabrg2 R43Q/+ and Hcn1 M294L/+ mice displayed spontaneous seizures recapitulating the human phenotypes. Single mutant Kcnh2 +/− mice exhibited an LQTS phenotype. Double mutant mice ( Gabrg2 R43Q/+ / Kcnh2 +/− and Hcn1 M294L/+ / Kcnh2 +/− ) had both seizure and prolonged QT interval phenotypes that were similar to their respective single mutant mice. Survival analysis revealed that Gabrg2 R43Q/+ / Kcnh2 +/− and Hcn1 M294L/+ / Kcnh2 +/− mice experienced a disproportionately higher rate of seizure‐related death when compared to wild‐type and their respective single mutant littermates. Oral administration of the cardiac‐selective β‐blocker atenolol significantly improved survival in Gabrg2 R43Q/+ / Kcnh2 +/− , Hcn1 M294L/+ , and Hcn1 M294L/+ / Kcnh2 +/− mice. Atenolol attenuated the sympathetic cardiac response to non‐terminal seizures. Significance The data support the premise that LOF KCNH2 variants can contribute to SUDEP risk in a subset of epilepsy patients. Our findings also highlight the potential use of β‐blockers as a prevention strategy in SUDEP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.
- School of Biosciences, University of Melbourne, Melbourne, Victoria, Australia.
- Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
ORCID-Profile: Ming S Soh, Alibek Kuanyshbek, Lauren E Bleakley, Christopher Semsarian, Ingrid E Scheffer, Samuel F Berkovic, Christopher A Reid
Förderung
- Anonymous Philanthropic Gift
- Australia's Medical Research Future Fund
- CURE Epilepsy
- Victorian Government Operational Infrastructure Support
- Australia's National Health and Medical Research Council
- Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme
- Citizens United for Research in Epilepsy
Zitieren
APA
Soh, M. S., Hu, A., Kuanyshbek, A., Mohamed Syazwan, E. S., Lee, H. M., McKenzie, C. E., Phillips, A. M., Bleakley, L. E., Semsarian, C., Scheffer, I. E., Berkovic, S. F., & Reid, C. A. (2026). Atenolol rescues premature mortality in genetic mouse models of sudden unexpected death in epilepsy. Epilepsia, 67(1), 448-462. https://doi.org/10.1111/epi.18642
Vancouver
Soh MS, Hu A, Kuanyshbek A, Mohamed Syazwan ES, Lee HM, McKenzie CE, et al. Atenolol rescues premature mortality in genetic mouse models of sudden unexpected death in epilepsy. Epilepsia. 2026;67(1):448-462. doi:10.1111/epi.18642
BibTeX
@article{Soh2026,
author = {Soh, Ming S and Hu, Amanda and Kuanyshbek, Alibek and Mohamed Syazwan, Erlina S and Lee, Hian M and McKenzie, Chaseley E and Phillips, A Marie and Bleakley, Lauren E and Semsarian, Christopher and Scheffer, Ingrid E and Berkovic, Samuel F and Reid, Christopher A},
title = {Atenolol rescues premature mortality in genetic mouse models of sudden unexpected death in epilepsy},
journal = {Epilepsia},
year = {2026},
volume = {67},
number = {1},
pages = {448--462},
doi = {10.1111/epi.18642}
}
EUVIMED